Evidence map›Paper›PMID 24811168›Full record

ArticleThe Journal of biological chemistry2014

Cdh1, a substrate-recruiting component of anaphase-promoting complex/cyclosome (APC/C) ubiquitin E3 ligase, specifically interacts with phosphatase and tensin homolog (PTEN) and promotes its removal from chromatin.

Byeong Hyeok Choi, Michele Pagano, Chaunshu Huang, Wei Dai

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Unmasking PTEN's nuclear functions.Cell cycle (Georgetown, Tex.) · 2016
    Article
  10. Article
  11. Article
  12. Review
  13. Nuclear PI3K signaling in cell growth and tumorigenesis.Frontiers in cell and developmental biology · 2015
    Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Byeong Hyeok ChoiFrom the Departments of Environmental Medicine, Biochemistry, and Molecular Pharmacology, New York University School of Medicine, Tuxedo, New York 10987.
Michele Paganothe Department of Pathology, New York University Cancer Institute, New York University School of Medicine, New York, New York 10016, and the Howard Hughes Medical Institute, New York University School of Medicine, New York, New York 10016.
Chaunshu HuangFrom the Departments of Environmental Medicine, Biochemistry, and Molecular Pharmacology, New York University School of Medicine, Tuxedo, New York 10987.
Wei DaiFrom the Departments of Environmental Medicine, Biochemistry, and Molecular Pharmacology, New York University School of Medicine, Tuxedo, New York 10987, wei.dai@nyumc.org.
New York University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
REGULATION OF THE GI PHASE BY THE UBIQUITIN PATHWAYR01GM057587 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 1998 to 2018
$7.8M
F-box proteins: deregulated cell cycle control and proteolysis in cancerR37CA076584 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 2006 to 2016
$4.7M
Molecular mechanisms underlying chromosomal instability and aneuploidyR01CA090658 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DAI, WEI · 2001 to 2012
$2.9M
Plk3, A New Player In The Hypoxia Regulatory Networ.R01CA150512 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DAI, WEI · 2011 to 2015
$1.6M
The Study of E3 Ligases and LongevityR21AG032560 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI DILLIN, ANDREW G · 2008 to 2009
$519k
Howard Hughes Medical InstituteNCI NIH HHS CA090658NCI NIH HHS CA150512NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA090658NCI NIH HHS R01 CA150512NCI NIH HHS R37 CA076584NIA NIH HHS R21 AG032560NIA NIH HHS R21-AG032560NIEHS NIH HHS ES000260NIEHS NIH HHS P30 ES000260NIGMS NIH HHS R01 GM057587NIGMS NIH HHS R01-GM057587
6 · The paper itself

Abstract

A pool of PTEN localizes to the nucleus. However, the exact mechanism by which nuclear PTEN is regulated remains unclear. We have recently reported that Plk1 specifically phosphorylates PTEN on Ser-380 during mitosis. Here we report that PTEN also localized to chromatin and that chromatin PTEN was removed by a proteasome-dependent process during mitotic exit. Pulldown analysis revealed that Cdh1, but not Cdc20, was significantly associated with PTEN. Cdh1 interacted with PTEN via two separate domains, and their interaction was enhanced by MG132, a proteasome inhibitor. Cdh1 negatively controlled the stability of chromatin PTEN by polyubiquitination. Phosphorylation of PTEN on Ser-380 impaired its interaction with Cdh1, thus positively regulating PTEN stability on chromatin. Significantly, the PTEN interaction with Cdh1 was phosphatase-independent, and Cdh1 knockdown via RNAi led to significant accumulation of chromatin PTEN, delaying mitotic exit. Combined, our studies identify Cdh1 as an important regulator of nuclear/chromatin PTEN during mitosis.

Indexed as

Anaphase-Promoting Complex-CyclosomeAntigens, CDCadherinsChromatinCysteine Proteinase InhibitorsEnzyme StabilityHeLa CellsHumansLeupeptinsMitosisPhosphorylationPTEN PhosphohydrolaseUbiquitinationUbiquitin-Protein LigasesAnaphase-Promoting Complex-CyclosomeAntigens, CDbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCadherinsCDH1 protein, humanChromatinCysteine Proteinase InhibitorsLeupeptinsPTEN PhosphohydrolasePTEN protein, humanUbiquitin-Protein LigasesCdh1Cell CycleChromatinE3 LigaseMitosisPhosphatase and Tensin Homolog (PTEN)ProteasomeProtein PhosphorylationUbiquitylation (Ubiquitination)

Identifiers

PMID24811168
PMCPMC4067225
OpenAlexW1974422169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.